Contemporary ASD Closure: A Review of FDA-Approved Devices and Patient-Specific Selection-Overview of the Current Devices and Evolving ASD Device Technology in the US: Towards the Ideal, Dr. Athar M. Qureshi

Overview of the Current Devices and Evolving ASD Device Technology in the US: Towards the Ideal, Dr. Athar M. Qureshi

Video Transcription

Video Summary

The speaker emphasizes their disclosure as a consultant for Gore and Bbron, but clarifies it doesn't relate to the AquaTech device. Focus shifts to device characteristics for ASD closures, highlighting user-friendliness, low-profile delivery, durability, and minimal complications risks, such as cardiac erosion or wireframe fractures. The presentation weighs on current devices like the ASO, AquaTech, and Gore Cardioform. Studies reveal varied outcomes, procedural successes, and complications. The Cardioform is noted for effective closures despite a 42% fracture rate without clinical consequences. Trial challenges for the Recept occluder are also discussed. Overall, the search for an ideal device continues.

Keywords

ASD closures

device characteristics

Cardioform

procedural success

Recept occluder